With the analysis among 84 patents, we discovered top 31 key players by total patent application. Ascendis Pharma Endocrinology Division A/S, Amunix Pharmaceuticals, Inc., Pharmacia Corp. are dominant in this area. They take 32.14% of the total patent filing.
California, United States
Patent: 9
New Jersey, United States
Patent: 8
Louisiana, United States
Patent: 3
Basel-Stadt, Switzerland
Patent: 2
Hovedstaden, Denmark
Patent: 2
California, United States
Patent: 2
No data, please try another search term
With the analysis among related 19 patents applied in the last 5 years. We discover 9 most active companies in this area. The fast-growing Ascendis Pharma Endocrinology Division A/S, Shanghai Meiyue Biotechnology Co., Ltd., JCR Pharmaceuticals Co., Ltd. take 26.32% of patent filing during this period.
Shanghai Meiyue Biotechnology Co., Ltd.
Shanghai Shi, China
Patent: 1
California, United States
Patent: 1
Shandong Sheng, China
Patent: 1
With the analysis among related 19 patents in last 5 years, we discover 7 new entrants. Shanghai Meiyue Biotechnology Co., Ltd., JCR Pharmaceuticals Co., Ltd., Ascendis Pharma GmbH are the most active new entrants in this area.
Shanghai Meiyue Biotechnology Co., Ltd.
Shanghai Shi, China
Patent: 1
Shandong Sheng, China
Patent: 1
No data, please try another search term